Corbus Pharmaceuticals (CRBP) PT Raised to $51 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Biren Amin raised the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $51.00 (from $35.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
